Leftagraph

Every financial statement,
one clean chart.

Search any US-listed company. Data straight from SEC filings.

PROBuild your own list with the screener

SILO PHARMA, INC. (SILO) financial statements

Number look wrong? Tell us

Data table
PROBuild your own list with the screener

SILO PHARMA, INC. (SILO), most recent 12 months reported: revenue $54.08K, net loss $4.47M. Latest balance sheet on file: liquid cash $5.23M. From SEC filings. Others in Pharmaceutical Preparations: IBIO, INC. · ASPIRE BIOPHARMA HOLDINGS, INC. · Actinium Pharmaceuticals, Inc. · AVALO THERAPEUTICS, INC. · LUNAI BIOWORKS INC. · ALTIMMUNE, INC. · NEONC TECHNOLOGIES HOLDINGS, INC. · Impact BioMedical, INC.

Stock screener

Watchlist